Hector Hugo Garcia

Summary

Affiliation: Johns Hopkins Bloomberg School of Public Health
Country: USA

Publications

  1. ncbi Hector Hugo García: promoting research on cysticercosis in Peru
    Barbara Fraser
    Lancet 370:1604. 2007
  2. ncbi Neurocysticercosis: is serology useful in the absence of brain imaging?
    Hector H Garcia
    Cysticercosis Unit, Instituto de Ciencias Neurologicas, Lima, Peru
    Trop Med Int Health 17:1014-8. 2012
  3. ncbi The effect on cardiovascular risk factors of migration from rural to urban areas in Peru: PERU MIGRANT Study
    J Jaime Miranda
    Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
    BMC Cardiovasc Disord 9:23. 2009
  4. ncbi Neurocysticercosis: unraveling the nature of the single cysticercal granuloma
    H H Garcia
    Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas, Jr Ancash 1271, Barrios Altos, Lima 1, Peru
    Neurology 75:654-8. 2010
  5. ncbi Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis
    Hector H Garcia
    Cysticercosis Unit, Department of Transmissible Diseases, Instituto Nacional de Ciencias Neurologicas, Jr Ancash 1271, Barrios Altos, Lima
    Br J Clin Pharmacol 72:77-84. 2011
  6. ncbi Cysticercosis of the central nervous system: how should it be managed?
    Hector H Garcia
    Department of Microbiology, Center for Global Health Tumbes, Universidad Peruana Cayetano Heredia, Lima, Peru
    Curr Opin Infect Dis 24:423-7. 2011
  7. ncbi Zoonotic helminth infections of humans: echinococcosis, cysticercosis and fascioliasis
    Hector H Garcia
    Department of Microbiology, School of Sciences, Universidad Peruana Cayetano Heredia, Lima, Peru
    Curr Opin Infect Dis 20:489-94. 2007
  8. ncbi Combined human and porcine mass chemotherapy for the control of T. solium
    H H Garcia
    Department of Microbiology, Universidad Peruana Cayetano Heredia, San Martin de Porras, Lima, Peru
    Am J Trop Med Hyg 74:850-5. 2006
  9. ncbi Neurocysticercosis: updated concepts about an old disease
    Hector H Garcia
    Cysticercosis Unit, Institute of Neurological Sciences, Lima, Peru
    Lancet Neurol 4:653-61. 2005
  10. ncbi New concepts in the diagnosis and management of neurocysticercosis (Taenia solium)
    Hector H Garcia
    Department of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Peru
    Am J Trop Med Hyg 72:3-9. 2005

Research Grants

  1. Neurocysticercosis: Combined Treatment with Praziquantel and Albendazole
    Hector Hugo Garcia; Fiscal Year: 2010
  2. Neurocysticercosis: Combined Treatment with Praziquantel and Albendazole
    Hector Garcia; Fiscal Year: 2007

Collaborators

Detail Information

Publications14

  1. ncbi Hector Hugo García: promoting research on cysticercosis in Peru
    Barbara Fraser
    Lancet 370:1604. 2007
  2. ncbi Neurocysticercosis: is serology useful in the absence of brain imaging?
    Hector H Garcia
    Cysticercosis Unit, Instituto de Ciencias Neurologicas, Lima, Peru
    Trop Med Int Health 17:1014-8. 2012
    ....
  3. ncbi The effect on cardiovascular risk factors of migration from rural to urban areas in Peru: PERU MIGRANT Study
    J Jaime Miranda
    Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
    BMC Cardiovasc Disord 9:23. 2009
    ..Thus the Peruvian context offers a unique opportunity to test the effects of migration...
  4. ncbi Neurocysticercosis: unraveling the nature of the single cysticercal granuloma
    H H Garcia
    Cysticercosis Unit, Instituto Nacional de Ciencias Neurologicas, Jr Ancash 1271, Barrios Altos, Lima 1, Peru
    Neurology 75:654-8. 2010
    ....
  5. ncbi Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis
    Hector H Garcia
    Cysticercosis Unit, Department of Transmissible Diseases, Instituto Nacional de Ciencias Neurologicas, Jr Ancash 1271, Barrios Altos, Lima
    Br J Clin Pharmacol 72:77-84. 2011
    ..We assessed the pharmacokinetics of their combined use for the treatment of neurocysticercosis...
  6. ncbi Cysticercosis of the central nervous system: how should it be managed?
    Hector H Garcia
    Department of Microbiology, Center for Global Health Tumbes, Universidad Peruana Cayetano Heredia, Lima, Peru
    Curr Opin Infect Dis 24:423-7. 2011
    ..Understanding of the main clinical presentations (dependent on number, location, size, and stage of parasites, as well as on the immune response of the host) allows a better view of treatment options and expected outcomes...
  7. ncbi Zoonotic helminth infections of humans: echinococcosis, cysticercosis and fascioliasis
    Hector H Garcia
    Department of Microbiology, School of Sciences, Universidad Peruana Cayetano Heredia, Lima, Peru
    Curr Opin Infect Dis 20:489-94. 2007
    ..This review summarizes current knowledge on clinical and epidemiologic aspects of zoonotic disease caused by tissue helminths...
  8. ncbi Combined human and porcine mass chemotherapy for the control of T. solium
    H H Garcia
    Department of Microbiology, Universidad Peruana Cayetano Heredia, San Martin de Porras, Lima, Peru
    Am J Trop Med Hyg 74:850-5. 2006
    ..Mass chemotherapy was effective in decreasing infection pressure in this hyperendemic area. However, the magnitude of the effect was small and did not attain the goal of eliminating transmission...
  9. ncbi Neurocysticercosis: updated concepts about an old disease
    Hector H Garcia
    Cysticercosis Unit, Institute of Neurological Sciences, Lima, Peru
    Lancet Neurol 4:653-61. 2005
    ..Meanwhile, updated information on diagnosis and management of neurocysticercosis is required, especially for clinicians who are unfamiliar with its wide array of clinical presentations...
  10. ncbi New concepts in the diagnosis and management of neurocysticercosis (Taenia solium)
    Hector H Garcia
    Department of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Peru
    Am J Trop Med Hyg 72:3-9. 2005
    ..These advances now permit a much better integration of clinical, serologic, and imaging data for diagnosis and therapeutic purposes...
  11. ncbi A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis
    Hector H Garcia
    Department of Transmissible Diseases, Instituto Nacional de Ciencias Neurologicas, Barrios Altos, Lima, Peru
    N Engl J Med 350:249-58. 2004
    ..Neurocysticercosis is the main cause of adult-onset seizures in the developing world. Whether therapy with antiparasitic agents results in improved seizure control has been questioned because of the lack of adequate, controlled studies...
  12. ncbi [Epidemiology and control of cysticercosis in Peru]
    Hector H Garcia
    Departamento de Microbiologia, Universidad Peruana Cayetano Heredia, Lima, Peru
    Rev Peru Med Exp Salud Publica 27:592-7. 2010
    ..Advances in the control of taeniasis/cysticercosis in our country open the road towards its elimination and potential eradication...
  13. ncbi Taenia solium oncosphere antigens induce immunity in pigs against experimental cysticercosis
    Manuela Verastegui
    Department of Pathology and Microbiology, Universidad Peruana Cayetano Heredia, Lima, Peru
    Vet Parasitol 108:49-62. 2002
    ..Although, antibody to these two antigens is consistently present in pigs that are protected from an oncosphere intramuscular challenge their role in preventing infection by T. solium larval cysts is still hypothetical...
  14. ncbi Epilepsy and toxocariasis: a case-control study in Italy
    Alessandra Nicoletti
    Department of Neurosciences, University of Catania, Catania, Italy
    Epilepsia 49:594-9. 2008
    ..To assess the relationship between epilepsy and toxocariasis in adult subjects by means of a case-control study in Catania, Italy...

Research Grants6

  1. Neurocysticercosis: Combined Treatment with Praziquantel and Albendazole
    Hector Hugo Garcia; Fiscal Year: 2010
    ..This mode of therapy would have worldwide applicability. The two sub-studies should add useful data on the pharmacokinetics of the drugs and assess the possibility of early prediction of complete cure. ..
  2. Neurocysticercosis: Combined Treatment with Praziquantel and Albendazole
    Hector Garcia; Fiscal Year: 2007
    ..This mode of therapy would have worldwide applicability. The two sub-studies should add useful data on the pharmacokinetics of the drugs and assess the possibility of early prediction of complete cure. ..